Cord blood as a potential therapeutic for amyotrophic lateral sclerosis

References

• Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–955.
   PubMed Web of Science ®Google Scholar
• Sorarù G, Ermani M, Logroscino G, et al. Natural history of upper motor neuron-dominant ALS. Amyotroph Lateral Scler. 2010;11:424–429.
   PubMed Web of Science ®Google Scholar
• Talbot K. Motor neuron disease: the bare essentials. Pract Neurol. 2009;9:303–309.
   PubMedGoogle Scholar
• Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772–1775.
   PubMed Web of Science ®Google Scholar
• Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7:710–723.
   PubMed Web of Science ®Google Scholar
• Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197–206.
   PubMed Web of Science ®Google Scholar
• Chen S, Sayana P, Zhang X, et al. Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener. 2013;8:28.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Thomson A, Kurien C, et al. Potential new complication in drug therapy development for amyotrophic lateral sclerosis. Expert Rev Neurother. 2016;16:1397–1405.
   PubMed Web of Science ®Google Scholar
• Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65(Suppl 1):S3–9.
   PubMed Web of Science ®Google Scholar
• Bruijn LI. Amyotrophic lateral sclerosis: from disease mechanisms to therapies. BioTechniques. 2002;32:1112, 1114, 1116 passim.
   Web of Science ®Google Scholar
• Strong MJ, Kesavapany S, Pant HC. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol. 2005;64:649–664.
   PubMed Web of Science ®Google Scholar
• Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
   PubMed Web of Science ®Google Scholar
• Martin LJ, Price AC, Kaiser A, et al. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review). Int J Mol Med. 2000;5:3–13.
   PubMed Web of Science ®Google Scholar
• Rodrigues MCO, Voltarelli JC, Sanberg PR, et al. Immunological aspects in amyotrophic lateral sclerosis. Transl Stroke Res. 2012;3:331–340.
   PubMed Web of Science ®Google Scholar
• Rodrigues MCO, Sanberg PR, Cruz LE, et al. The innate and adaptive immunological aspects in neurodegenerative diseases. J Neuroimmunol. 2014;269:1–8.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Henderson RD. The role of immune and inflammatory mechanisms in ALS. Curr Mol Med. 2011;11:246–254.
   PubMed Web of Science ®Google Scholar
• D’Amico E, Factor-Litvak P, Santella RM, et al. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med. 2013;65:509–527.
   PubMed Web of Science ®Google Scholar
• Papadimitriou D, Le Verche V, Jacquier A, et al. Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis. 2010;37:493–502.
   PubMed Web of Science ®Google Scholar
• Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8:888–899.
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Chun SJ, Boillee S, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11:251–253.
   PubMed Web of Science ®Google Scholar
• Boillée S, Yamanaka K, Lobsiger CS, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389–1392.
   PubMed Web of Science ®Google Scholar
• Appel SH, Smith RG, Engelhardt JI, et al. Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(Suppl):14–19.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Haller E, Saporta S, et al. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 2007;1157:126–137.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Saporta S, Haller E, et al. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE. 2007;2:e1205.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MCO, et al. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114–128.
   PubMed Web of Science ®Google Scholar
• Nicaise C, Mitrecic D, Demetter P, et al. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009;1301:152–162.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Deane R, Ali Z, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci. 2008;11:420–422.
   PubMed Web of Science ®Google Scholar
• Miyazaki K, Ohta Y, Nagai M, et al. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res. 2011;89:718–728.
   PubMed Web of Science ®Google Scholar
• Henkel JS, Beers DR, Wen S, et al. Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology. 2009;72:1614–1616.
   PubMed Web of Science ®Google Scholar
• Winkler EA, Sengillo JD, Sullivan JS, et al. Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:111–120.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Rodrigues MCO, Hernandez-Ontiveros DG, et al. Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res. 2011;1398:113–125.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Saporta S, Sanberg PR. Implications of blood-brain barrier disruption in ALS. Amyotroph Lateral Scler. 2008;9:375–376.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Sanberg PR. Blood-CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci. 2014;8:21.
   PubMed Web of Science ®Google Scholar
• Yan J, Xu L, Am W, et al. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells. 2006;24:1976–1985.
   PubMed Web of Science ®Google Scholar
• Xu L, Yan J, Chen D, et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation. 2006;82:865–875.
   PubMed Web of Science ®Google Scholar
• Mitrecić D, Nicaise C, Gajović S, et al. differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transplant. 2010;19:537–548.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Ae W, Milliken M, et al. Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:175–180.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Milliken M, et al. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp Neurol. 2002;174:169–180.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Saporta S, et al. Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 2006;7:221–226.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Sanberg PR. Feasibility of cell therapy for amyotrophic lateral sclerosis. Exp Neurol. 2009;216:3–6.
   PubMed Web of Science ®Google Scholar
• Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med. 2004;10(Suppl):S42–S50.
   PubMed Web of Science ®Google Scholar
• Rizzo F, Riboldi G, Salani S, et al. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci. 2014;71:999–1015.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Svendsen CN. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci. 2008;31:192–198.
   PubMed Web of Science ®Google Scholar
• Lunn JS, Hefferan MP, Marsala M, et al. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. Growth Factors. 2009;27:133–140.
   PubMed Web of Science ®Google Scholar
• Haidet-Phillips AM, Maragakis NJ. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS). Brain Res. 2015;1628:343–350.
   PubMed Web of Science ®Google Scholar
• Chen KS, Sakowski SA, Feldman EL. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis. Ann Neurol. 2016;79:342–353.
   PubMed Web of Science ®Google Scholar
• Faravelli I, Riboldi G, Nizzardo M, et al. Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation. Cell Mol Life Sci. 2014;71:3257–3268.
   PubMed Web of Science ®Google Scholar
• Thomsen GM, Gowing G, Svendsen S, et al. The past, present and future of stem cell clinical trials for ALS. Exp Neurol. 2014;262(Pt B):127–137.
   PubMed Web of Science ®Google Scholar
• Lunn JS, Sakowski SA, Feldman EL. Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future. Stem Cells. 2014;32:1099–1109.
   PubMed Web of Science ®Google Scholar
• Boulis NM, Federici T, Glass JD, et al. Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;8:172–176.
   PubMed Web of Science ®Google Scholar
• Haim ED, Williams SN, Sanberg PR, et al. Recent Patents in Cell Therapy for Amyotrophic Lateral Sclerosis. Recent Patents on Regenerative Medicine. 2015;5:10–19.
   Google Scholar
• Sanberg PR, Willing AE, Cahill DW. Novel cellular approaches to repair of neurodegenerative disease: from Sertoli cells to umbilical cord blood stem cells. Neurotox Res. 2002;4:95–101.
   PubMedGoogle Scholar
• Sanberg PR, Willing AE, Garbuzova-Davis S, et al. Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci. 2005;1049:67–83.
   PubMed Web of Science ®Google Scholar
• Sanberg PR, Eve DJ, Willing AE, et al. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant. 2011;20:85–94.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Saporta S, et al. Novel cell therapy approaches for brain repair. Prog Brain Res. 2006;157:207–222.
   PubMed Web of Science ®Google Scholar
• Low CB, Liou Y-C, Tang BL. Neural differentiation and potential use of stem cells from the human umbilical cord for central nervous system transplantation therapy. J Neurosci Res. 2008;86:1670–1679.
   PubMed Web of Science ®Google Scholar
• McGuckin CP, Forraz N, Baradez M-O, et al. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 2005;38:245–255.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy. 2005;7:219–227.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE. Umbilical cord transplantation: epilogue. Semin Hematol. 2010;47:97–103.
   PubMed Web of Science ®Google Scholar
• Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122:491–498.
   PubMed Web of Science ®Google Scholar
• Roura S, Pujal J-M, Gálvez-Montón C, et al. The role and potential of umbilical cord blood in an era of new therapies: a review. Stem Cell Res Ther. 2015;6:123.
   PubMed Web of Science ®Google Scholar
• Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846–1854.
   PubMed Web of Science ®Google Scholar
• Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001;97:2962–2971.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE. Primitive hematopoietic stem and progenitor cells in human umbilical cord blood: an alternative source of transplantable cells. Cancer Treat Res. 1996;84:139–148.
   PubMedGoogle Scholar
• Cardoso AA, Li ML, Batard P, et al. Human umbilical cord blood CD34+ cell purification with high yield of early progenitors. J Hematother. 1993;2:275–279.
   PubMedGoogle Scholar
• Mayani H, Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells. 1998;16:153–165.
   PubMed Web of Science ®Google Scholar
• Nayar B, Raju GMK, Deka D. Hematopoietic stem/progenitor cell harvesting from umbilical cord blood. Int J Gynaecol Obstet. 2002;79:31–32.
   PubMed Web of Science ®Google Scholar
• Todaro AM, Pafumi C, Pernicone G, et al. Haematopoietic progenitors from umbilical cord blood. Blood Purif. 2000;18:144–147.
   PubMed Web of Science ®Google Scholar
• Bicknese AR, Goodwin HS, Quinn CO, et al. Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant. 2002;11:261–264.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos JR, Song S, Kamath SG, et al. Expression of neural markers in human umbilical cord blood. Exp Neurol. 2001;171:109–115.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos JR. Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res. 2002;69:880–893.
   PubMed Web of Science ®Google Scholar
• Chen N, Hudson JE, Walczak P, et al. Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells. 2005;23:1560–1570.
   PubMed Web of Science ®Google Scholar
• Zola H, Fusco M, Macardle PJ, et al. Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes. Pediatr Res. 1995;38:397–403.
   PubMed Web of Science ®Google Scholar
• Rainsford E, Reen DJ. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol. 2002;116:702–709.
   PubMed Web of Science ®Google Scholar
• Vendrame M, Gemma C, Mesquita DD, et al. Anti-inflammatory Effects of Human Cord Blood Cells in a Rat Model of Stroke. Stem Cells Dev. 2005;14:595–604.
   PubMed Web of Science ®Google Scholar
• Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682–2688.
   PubMed Web of Science ®Google Scholar
• Ae W, Lixian J, Milliken M, et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res. 2003;73:296–307.
   PubMed Web of Science ®Google Scholar
• Nikolic WV, Hou H, Town T, et al. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev. 2008;17:423–439.
   PubMed Web of Science ®Google Scholar
• Darlington D, Deng J, Giunta B, et al. Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-β-associated neuropathology in Alzheimer mice. Stem Cells Dev. 2013;22:412–421.
   PubMed Web of Science ®Google Scholar
• Darlington D, Li S, Hou H, et al. Human umbilical cord blood-derived monocytes improve cognitive deficits and reduce amyloid-β pathology in PSAPP mice. Cell Transplant. 2015;24:2237–2250.
   PubMed Web of Science ®Google Scholar
• Ehrhart J, Darlington D, Kuzmin-Nichols N, et al. Bio-distribution of Infused human umbilical cord blood cells in Alzheimer’s disease-like murine model. Cell Transplant.  2016;25:195–199.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Klasko SK, Sanberg PR. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B. J Comp Neurol. 2009;515:93–101.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Desjarlais T, et al. Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B. Stem Cells Dev. 2005;14:384–394.
   PubMed Web of Science ®Google Scholar
• Willing AE, Garbuzova-Davis SN, Zayko O, et al. Repeated administrations of human umbilical cord blood cells improve disease outcomes in a mouse model of Sanfilippo syndrome type III B. Cell Transplant. 2014;23:1613–1630.
   PubMed Web of Science ®Google Scholar
• Lu D, Sanberg PR, Mahmood A, et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 2002;11:275–281.
   PubMed Web of Science ®Google Scholar
• De La Peña I, Sanberg PR, Acosta S, et al. G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury. Cell Transplant. 2015;24:447–457.
   PubMed Web of Science ®Google Scholar
• Saporta S, Kim -J-J, Willing AE, et al. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res. 2003;12:271–278.
   PubMedGoogle Scholar
• Pranke P, Failace RR, Allebrandt WF, et al. Hematologic and immunophenotypic characterization of human umbilical cord blood. Acta Haematol. 2001;105:71–76.
   PubMed Web of Science ®Google Scholar
• Newcomb JD, Sanberg PR, Klasko SK, et al. Umbilical cord blood research: current and future perspectives. Cell Transplant. 2007;16:151–158.
   PubMed Web of Science ®Google Scholar
• Harris DT, Schumacher MJ, Locascio J, et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA. 1992;89:10006–10010.
   PubMed Web of Science ®Google Scholar
• D’Arena G, Musto P, Cascavilla N, et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica. 1998;83:197–203.
   PubMed Web of Science ®Google Scholar
• Han P, Hodge G, Story C, et al. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol. 1995;89:733–740.
   PubMed Web of Science ®Google Scholar
• Saudemont A, Madrigal JA. Immunotherapy after hematopoietic stem cell transplantation using umbilical cord blood-derived products. Cancer Immunol Immunother. 2017;66:215–221.
   PubMed Web of Science ®Google Scholar
• Prabhu SB, Rathore DK, Nair D, et al. Comparison of Human Neonatal and Adult Blood Leukocyte Subset Composition Phenotypes. PLoS ONE. 2016;11:e0162242.
   PubMed Web of Science ®Google Scholar
• Mayani H. Umbilical cord blood: lessons learned and lingering challenges after more than 20 years of basic and clinical research. Arch Med Res. 2011;42:645–651.
   PubMed Web of Science ®Google Scholar
• Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 1997;89:3919–3924.
   PubMed Web of Science ®Google Scholar
• Nimgaonkar MT, Roscoe RA, Persichetti J, et al. A unique population of CD34+ cells in cord blood. Stem Cells. 1995;13:158–166.
   PubMed Web of Science ®Google Scholar
• Körbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood. 2001;98:2900–2908.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Keating A, Nayar R, et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol. 1994;22:1003–1010.
   PubMed Web of Science ®Google Scholar
• Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235–242.
   PubMed Web of Science ®Google Scholar
• Yang S-E, Ha C-W, Jung M, et al. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy. 2004;6:476–486.
   PubMed Web of Science ®Google Scholar
• Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal “stem” cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 2003;121:368–374.
   PubMed Web of Science ®Google Scholar
• Martins AA, Paiva A, Morgado JM, et al. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant Proc. 2009;41:943–946.
   PubMed Web of Science ®Google Scholar
• Musina RA, Bekchanova ES, Belyavskii AV, et al. Umbilical cord blood mesenchymal stem cells. Bull Exp Biol Med. 2007;143:127–131.
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294–1301.
   PubMed Web of Science ®Google Scholar
• Jin HJ, Bae YK, Kim M, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14:17986–18001.
   PubMed Web of Science ®Google Scholar
• Lee MW, Jang IK, Yoo KH, et al. Stem and progenitor cells in human umbilical cord blood. Int J Hematol. 2010;92:45–51.
   PubMed Web of Science ®Google Scholar
• Van De Ven C, Collins D, Bradley MB, et al. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Exp Hematol. 2007;35:1753–1765.
   PubMed Web of Science ®Google Scholar
• McGuckin CP, Forraz N. Potential for access to embryonic-like cells from human umbilical cord blood. Cell Prolif. 2008;41(Suppl 1):31–40.
   PubMed Web of Science ®Google Scholar
• Rogers I, Casper RF. Stem cells: you can’t tell a cell by its cover. Hum Reprod Update. 2003;9:25–33.
   PubMed Web of Science ®Google Scholar
• Rogers I, Casper RF. Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol. 2004;18:893–908.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Mugishima H. Non-hematopoietic stem cells in umbilical cord blood. Int J Stem Cells. 2009;2:83–89.
   PubMedGoogle Scholar
• Coelho P, Baker B, Chapman J, et al. Stem and Progenitor Cell Compositions Recovered from Bone Marrow or Cord Blood; System and Method for Preparation Thereof. WO/2008/121120, 2008
   Google Scholar
• Garbuzova-Davis S, Balber A, Davis-Sanberg C, et al. Treating amyotrophic lateral sclerosis (ALS) with isolated aldehyde dehydrogenase-positive umbilical cord blood cells. US8765119 B2, 2014
   Google Scholar
• Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104:2752–2760.
   PubMed Web of Science ®Google Scholar
• Nieda M, Nicol A, Denning-Kendall P, et al. Endothelial cell precursors are normal components of human umbilical cord blood. Br J Haematol. 1997;98:775–777.
   PubMed Web of Science ®Google Scholar
• Mead LE, Prater D, Yoder MC, et al. Isolation and characterization of endothelial progenitor cells from human blood. Curr Protoc Stem Cell Biol. 2008;Chapter 2:Unit 2C.1.
   PubMedGoogle Scholar
• Duan H-X, Cheng L-M, Wang J, et al. Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood. Cell Biol Int. 2006;30:1018–1027.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Benninger L, Yip-Schneider M, et al. Commentary: a rapid proliferation assay for unknown co-stimulating factors in cord blood plasma possibly involved in enhancement of in vitro expansion and replating capacity of human hematopoietic stem/progenitor cells. Blood Cells. 1994;20:492–497.
   PubMedGoogle Scholar
• Kim Y-M, Jung M-H, Song H-Y, et al. Ex vivo expansion of human umbilical cord blood-derived T-lymphocytes with homologous cord blood plasma. Tohoku J Exp Med. 2005;205:115–122.
   PubMed Web of Science ®Google Scholar
• Bojanić I, Golubić Cepulić B. Umbilical cord blood as a source of stem cells. Acta Med Croatica. 2006;60:215–225.
   PubMedGoogle Scholar
• Buzanska L, Machaj EK, Zablocka B, et al. Human cord blood-derived cells attain neuronal and glial features in vitro. J Cell Sci. 2002;115:2131–2138.
   PubMed Web of Science ®Google Scholar
• Buzańska L, Jurga M, Domańska-Janik K. Neuronal differentiation of human umbilical cord blood neural stem-like cell line. Neurodegener Dis. 2006;3:19–26.
   PubMed Web of Science ®Google Scholar
• Ha Y, Choi JU, Yoon DH, et al. Neural phenotype expression of cultured human cord blood cells in vitro. Neuroreport. 2001;12:3523–3527.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Zigova T, et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res. 2003;12:255–270.
   PubMedGoogle Scholar
• Chen N, Kamath S, Newcomb J, et al. Trophic factor induction of human umbilical cord blood cells in vitro and in vivo. J Neural Eng. 2007;4:130–145.
   PubMed Web of Science ®Google Scholar
• Chen N, Newcomb J, Garbuzova-Davis S, et al. Human Umbilical Cord Blood Cells Have Trophic Effects on Young and Aging Hippocampal Neurons in Vitro. Aging Dis. 2010;1:173–190.
   PubMed Web of Science ®Google Scholar
• Newman MB, Willing AE, Manresa JJ, et al. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol. 2006;199:201–208.
   PubMed Web of Science ®Google Scholar
• Neuhoff S, Moers J, Rieks M, et al. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp Hematol. 2007;35:1119–1131.
   PubMed Web of Science ®Google Scholar
• Fan C-G, Zhang Q-J, Tang F-W, et al. Human umbilical cord blood cells express neurotrophic factors. Neurosci Lett. 2005;380:322–325.
   PubMed Web of Science ®Google Scholar
• Rizvanov AA, Kiyasov AP, Gaziziov IM, et al. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. Neurochem Int. 2008;53:389–394.
   PubMed Web of Science ®Google Scholar
• Eggermann J, Kliche S, Jarmy G, et al. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res. 2003;58:478–486.
   PubMed Web of Science ®Google Scholar
• Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol. 2003;23:1185–1189.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Hangoc G, Cooper S, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA. 1992;89:4109–4113.
   PubMed Web of Science ®Google Scholar
• Gilmore GL, DePasquale DK, Lister J, et al. Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells. Exp Hematol. 2000;28:1297–1305.
   PubMed Web of Science ®Google Scholar
• Koestenbauer S, Zisch A, Dohr G, et al. Protocols for hematopoietic stem cell expansion from umbilical cord blood. Cell Transplant. 2009;18:1059–1068.
   PubMed Web of Science ®Google Scholar
• Ko K-H, Nordon R, O’Brien TA, et al. Ex Vivo Expansion of Hematopoietic Stem Cells to Improve Engraftment in Stem Cell Transplantation. Methods Mol Biol. 2017;1524:301–311.
   PubMedGoogle Scholar
• Ende N, Weinstein F, Chen R, et al. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci. 2000;67:53–59. .
   PubMed Web of Science ®Google Scholar
• Chen R, Ende N. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med. 2000;31:21–30.
   PubMedGoogle Scholar
• Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE. 2008;3:e2494.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Rodrigues MCO, Mirtyl S, et al. Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS. PLoS ONE. 2012;7:e31254.
   PubMed Web of Science ®Google Scholar
• Souayah N, Coakley KM, Chen R, et al. Defective neuromuscular transmission in the SOD1 G93A transgenic mouse improves after administration of human umbilical cord blood cells. Stem Cell Rev. 2012;8:224–228.
   PubMed Web of Science ®Google Scholar
• Knippenberg S, Thau N, Schwabe K, et al. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis. 2012;9:107–120.
   PubMed Web of Science ®Google Scholar
• Willenbrock S, Knippenberg S, Meier M, et al. In vivo MRI of intraspinally injected SPIO-labelled human CD34+ cells in a transgenic mouse model of ALS. In Vivo. 2012;26:31–38.
   PubMed Web of Science ®Google Scholar
• Habisch H-J, Janowski M, Binder D, et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm (Vienna). 2007;114:1395–1406.
   PubMed Web of Science ®Google Scholar
• Bigini P, Veglianese P, Andriolo G, et al. Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration. Rejuvenation Res. 2011;14:623–639.
   PubMed Web of Science ®Google Scholar
• Mukhamedyarov MA, Rizvanov AA, Safiullov ZZ, et al. Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype. Bull Exp Biol Med. 2013;154:558–561.
   PubMed Web of Science ®Google Scholar
• Rizvanov AA, Guseva DS, Salafutdinov II, et al. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice. Exp Biol Med (Maywood). 2011;236:91–98.
   PubMed Web of Science ®Google Scholar
• Garanina EE, Mukhamedshina YO, Salafutdinov II, et al. Construction of recombinant adenovirus containing picorna-viral 2A-peptide sequence for the co-expression of neuro-protective growth factors in human umbilical cord blood cells. Spinal Cord. 2016;54:423–430.
   PubMed Web of Science ®Google Scholar
• Guseva D, Rizvanov AA, Salafutdinov II, et al. Over-expression of Oct4 and Sox2 transcription factors enhances differentiation of human umbilical cord blood cells in vivo. Biochem Biophys Res Commun. 2014;451:503–509.
   PubMed Web of Science ®Google Scholar
• Islamov RR, Rizvanov AA, Mukhamedyarov MA, et al. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule. Curr Gene Ther. 2015;15:266–276.
   PubMed Web of Science ®Google Scholar
• Islamov RR, Rizvanov AA, Fedotova VY, et al. Tandem Delivery of Multiple Therapeutic Genes Using Umbilical Cord Blood Cells Improves Symptomatic Outcomes in ALS. Mol Neurobiol. 2016.Epub Aug 6.
   PubMedGoogle Scholar
• Freireich EJ, Gehan EA, Rall DP, et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966;50:219–244.
   PubMedGoogle Scholar
• Cabanes C, Bonilla S, Tabares L, et al. Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration. Neurobiol Dis. 2007;26:408–418.
   PubMed Web of Science ®Google Scholar
• Gubert F, Decotelli AB, Bonacossa-Pereira I, et al. Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis. Stem Cell Res Ther. 2016;7:41.
   PubMed Web of Science ®Google Scholar
• Knopf PM, Cserr HF, Nolan SC, et al. Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain. Neuropathol Appl Neurobiol. 1995;21:175–180.
   PubMed Web of Science ®Google Scholar
• Calias P, Banks WA, Begley D, et al. Intrathecal delivery of protein therapeutics to the brain: a critical reassessment. Pharmacol Ther. 2014;144:114–122.
   PubMed Web of Science ®Google Scholar
• Ehrhart J, Smith AJ, Kuzmin-Nichols N, et al. Humoral factors in ALS patients during disease progression. J Neuroinflammation. 2015;12:127.
   PubMed Web of Science ®Google Scholar
• Teng YD, Yu D, Ropper AE, et al. Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research. Curr Neuropharmacol. 2011;9:574–585.
   PubMed Web of Science ®Google Scholar
• Deda H, Inci MC, Kürekçi AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy. 2009;11:18–25.
   PubMed Web of Science ®Google Scholar
• Kim C, Lee HC, Sung -J-J. Amyotrophic lateral sclerosis - cell based therapy and novel therapeutic development. Exp Neurobiol. 2014;23:207–214.
   PubMedGoogle Scholar
• Gelati M, Profico D, Projetti-Pensi M, et al. Culturing and expansion of “clinical grade” precursors cells from the fetal human central nervous system. Methods Mol Biol. 2013;1059:65–77.
   PubMedGoogle Scholar
• Mazzini L, Gelati M, Profico DC, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015;13:17.
   PubMed Web of Science ®Google Scholar
• Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, et al. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy. 2009;11:26–34.
   PubMed Web of Science ®Google Scholar